Clinical Trial Update: The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO

View source ↗

Summary

The PROOF trial, a prospective open-label multicenter non-randomized study evaluating percutaneous closure of patent foramen ovale with the Occlutech PFO Occlud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Foramen Ovale
• Stroke

Snippet

Sponsor: Occlutech International AB | Conditions: Stroke, PFO - Patent Foramen Ovale | Status: TERMINATED